New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant-induced hypogammaglobulinemia

Clinical and Experimental Neuroimmunology

Volumn 6, Issue 1, 2015, Pages 83-88

  Ameratunga, Rohan ^a   Lindsay, Karen ^a   Woon, See Tarn ^a   Jordan, Anthony ^a   Anderson, Neil E ^a   Koopmans, Wikke ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

anticonvulsants; common variable immunodeficiency disorder; hypogammaglobulinemia

Indexed keywords

ETIRACETAM; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMOTRIGINE; VACCINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSTIC VALUE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPTIC DISCHARGE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; INTERSTITIAL PNEUMONIA; PLASMA CELL; PRIORITY JOURNAL; SEIZURE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84961289699     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12135     Document Type: Article

References (37)

1. Ameratunga R, Casey P, Parry S, Kendi C,. Hypogammaglobulinemia factitia. Munchausen syndrome presenting as Common Variable Immune Deficiency. Allergy Asthma and Clin Immunol. 2013; 9: 36-41.
2. Duraisingham SS, Buckland MS, Grigoriadou S, Longhurst HJ,. Secondary antibody deficiency. Expert Rev Clin Immunol. 2014; 10: 583-91.
3. Smith J, Fernando T, McGrath N, Ameratunga R,. Lamotrigine-induced common variable immune deficiency. Neurology. 2004; 62: 833-4.
4. Pereira LF, Sanchez JF,. Reversible panhypogammaglobulinemia associated with phenytoin treatment. Scand J Infect Dis. 2002; 34: 785-7.
5. Hoshino C, Hoshi T,. Carbamazepine-induced agammagloblinaemia clinically mimicking diffuse panbronchiolitis. BMJ Case Rep. 2011; 2011: pii: bcr1120103535.
6. Yamamoto T, Uchiyama T, Takahashi H, Himuro K, Kanai K, Kuwabara S,. B cell aplasia and hypogammaglobulinemia after carbamazepine treatment. Intern Med. 2010; 49: 707-8.
7. Gaig P, Garcia-Ortega P, Baltasar M, Bartra J,. Drug neosensitization during anticonvulsant hypersensitivity syndrome. J Investig Allergol Clin Immunol. 2006; 16: 321-6.
8. Conley ME, Notarangelo LD, Etzioni A,. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999; 93: 190-7.
9. Agarwal S, Cunningham-Rundles C,. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007; 99: 281-3.
10. Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R,. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013; 174: 203-11.
11. Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R,. New diagnostic criteria for CVID. Expert Rev Clin Immunol. 2014; 10: 183-6.
12. Daniels JA, Lederman HM, Maitra A, Montgomery EA,. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007; 31: 1800-12.
13. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008; 46: 1547-54.
14. Zar HJ,. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol. 2008; 43: 1-10.
15. Ashrafi M, Hosseini SA, Abolmaali S, et al. Effect of anti-epileptic drugs on serum immunoglobulin levels in children. Acta Neurol Belg. 2010; 110: 65-70.
16. Svalheim S, Mushtaq U, Mochol M, et al. Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine. Acta Neurol Scand Suppl. 2013; 127: 11-5.
17. Castro AP, Redmershi MG, Pastorino AC, de Paz JA, Fomin AB, Jacob CM,. Secondary hypogammaglobilinemia after use of carbamazepine: case report and review. Rev Hosp Clin Fac Med Sao Paulo. 2001; 56: 189-92.
18. Chapel H, Cunningham-Rundles C,. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009; 145: 709-27.
19. Knight AK, Cunningham-Rundles C,. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev. 2006; 5: 156-9.
20. Cunningham-Rundles C, Bodian C,. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999; 92: 34-48.
21. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008; 112: 277-86.
22. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008; 111: 77-85.
23. Abrahamian F, Agrawal S, Gupta S,. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol. 2010; 159: 344-50.
24. Olinder-Nielsen AM, Granert C, Forsberg P, Friman V, Vietorisz A, Bjorkander J,. Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up. Scand J Infect Dis. 2007; 39: 44-50.
25. Musher DM, Manof SB, Liss C, et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010; 201: 516-24.
26. Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R,. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J Clin Immunol. 2013; 33: 68-73.
27. Tiller TL Jr, Buckley RH,. Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up. J Pediatr. 1978; 92: 347-53.
28. Pan-Hammarstrom Q, Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007; 39: 429-30.
29. Salzer U, Bacchelli C, Buckridge S, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009; 113: 1967-76.
30. Popa V,. Lymphocytic interstitial pneumonia of common variable immunodeficiency. Ann Allergy. 1988; 60: 203-6.
31. Ameratunga R, Becroft DM, Hunter W,. The simultaneous presentation of sarcoidosis and common variable immune deficiency. Pathology. 2000; 32: 280-2.
32. Fasano MB, Sullivan KE, Sarpong SB, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore). 1996; 75: 251-61.
33. Fuss IJ, Friend J, Yang Z, et al. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol. 2013; 33: 748-58.
34. Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol. 2008; 48: 74-82.
35. Luzi G, Zullo A, Iebba F, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol. 2003; 98: 118-21.
36. Malamut G, Verkarre V, Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010; 105: 2262-75.
37. Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L,. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011; 17: 251-9.